|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 12.73 USD | +0.55% |
|
+3.16% | -18.50% |
| 08-18 | Tonix Pharmaceuticals Holding Corp. Announces Appointment of Seth Lederman as Interim Chief Medical Officer | CI |
| 08-10 | Tonix Pharmaceuticals Holding Corp., Q2 2026 Earnings Call, Aug 10, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
TNXP 12.73 $
+0.55%
7.62M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| TNXP | 12.73USD | +0.55% | 7.62M $ | |
CBOE
| TNXP | 12.71USD | +0.55% | 214K $ | |
|
Tradegate
| TPM0 | 10.90EUR | -0.41% | 8.88K € | |
|
Deutsche Boerse AG
| TPM0 | 10.71EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 13.03 | 13.03 | 15.74 |
| Spread/Res. | -2.30% | -2.30% | -19.12% |
| Spread/Supp. | +33.86% | +33.86% | +28.85% |
| Support | 9.51 | 9.51 | 9.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TNXP Stock
- Charts Tonix Pharmaceuticals Holding Corp.
Select your edition
All financial news and data tailored to specific country editions
